Drug Alert: CDSCO flags 83 formulations as not of standard quality - Video

Published On 2022-12-15T17:30:56+05:30 | Updated On 15 Dec 2022 5:30 PM IST

Overview

In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 83 medicine batches for failing to qualify for a random drug sample test for the month of November, 2022.

These drugs samples which are declared not of standard quality include Pantop-DSR (Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged- release Capsules IP) manufactured by Aristo Pharmaceuticals, SHELCAL-500 (Calcium And Vitamin D3 Tablets I.P.) manufactured by Pure and Cure Healthcare, Paracetamol Tablets IP 650mg manufactured by ANG Lifesciences India, Montelukast Sodium Tablets IP 5 mg manufactured by Skymap Pharmaceuticals and others.

For more details, check out the link given below:

83 Drug Samples Fail To Qualify CDSCO Test

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751